Treatment of Protein C Deficiency in Postpartum Women with a First-Degree Family History of VTE

The postpartum period is a period of elevated thrombotic risk. In women with Protein C deficiency who also have a first-degree family history of venous thromboembolism (VTE), this risk takes on added clinical significance and warrants a structured management response.

Clinical Scenario

        Female patient in the postpartum period with Protein C deficiency and a first-degree family history of venous thromboembolism.
      

Management Approach

Evidence-based guidance supports postpartum thromboprophylaxis in this setting. The complete structured regimen — including the specific intervention, timing, and duration — is outlined in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/jth.15732

For women with a first-degree family history of VTE and known homozygous FVL, a combination of FVL and PGM, antithrombin deficiency, protein C deficiency, or protein S deficiency in the family, the ASH guideline panel suggests testing for the known familial thrombophilia.

The panel determined that on balance, with small effects (preventing VTE in the postpartum period) and trivial undesirable effects (more major bleeding) for women with a sibling with homozygous FVL and women with a first-degree family history of a combination of FVL and PGM, or antithrombin, protein C, or protein S deficiency, a strategy of testing for thrombophilia and thromboprophylaxis postpartum in women with thrombophilia would probably be favored.

Thromboprophylaxis postpartum continues until 6 weeks after delivery.

View source ↗